The promoting angiogenesis and anti-inflammation effect of scutellarin on polyglycolic acid scaffold of balb/c mice model

Journal of Asian Natural Products Research

Volumn 10, Issue 12, 2008, Pages 1147-1153

  Ma, Jing Yuan ^a   Jiang, Wei Wen ^a   Zhou, Zeng Tong ^a   Li, Jing Min ^b   Wang, Hai Yan ^a  

^a SHANGHAI JIAO TONG UNIVERSITY   (China)

^b Hangzhou Stomatological Hospital   (China)

Author keywords

Angiogenesis; Inflammation; Polyglycolic acid; Scutellarin

Indexed keywords

FIBROBLAST GROWTH FACTOR; MESSENGER RNA; POLYGLYCOLIC ACID; SCUTELLAREIN; VASCULOTROPIN;

ANGIOGENESIS; ANIMAL EXPERIMENT; ANIMAL TISSUE; ANTIINFLAMMATORY ACTIVITY; ARTICLE; BAGG ALBINO MOUSE; CONTROLLED STUDY; EXPERIMENTAL MODEL; HISTOPATHOLOGY; IMMUNOHISTOCHEMISTRY; INFLAMMATORY CELL; MALE; MOUSE; NONHUMAN; PROTEIN EXPRESSION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; TISSUE ENGINEERING;

ANIMALS; ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; APIGENIN; BIOCOMPATIBLE MATERIALS; GENE EXPRESSION REGULATION; GLUCURONIC ACIDS; INFLAMMATION; MALE; MICE; MICE, INBRED BALB C; MOLECULAR STRUCTURE; NEOVASCULARIZATION, PHYSIOLOGIC; POLYGLYCOLIC ACID; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA; TISSUE ENGINEERING; VASCULAR ENDOTHELIAL GROWTH FACTOR A;

MUS;

EID: 56749185235     PISSN: 10286020     EISSN: 14772213     Source Type: Journal    
DOI: 10.1080/10286020802361255     Document Type: Article

References (16)

1. P.K. Yarlagadda, M. Chandrasekharan, and J.Y. Shyan, Biomed. Mater. Eng. 15, 159 (2005).
2. P. Carmeliet and R.K. Jain, Nature 407, 249 (2000).
3. R.J. Schott and L.A. Morrow, Cardiovasc. Res. 27, 1155 (1993).
4. L.D. Shea, E. Smiley, J. Bonadio, and D.J. Mooney, Nat. Biotechnol. 17, 551 (1999).
5. H. Liu, X.L. Yang, Y. Wang, X.Q. Tang, D.Y. Jiang, and H.B. Xu, Acta. Pharmacol. Sin. 24, 1113 (2003).
6. X.F. Yang, W. He, W.H. Lu, and F.D. Zeng, Acta. Pharmacol. Sin. 24, 1118 (2003).
7. X.M. Hu and M.M. Zhou, Acta. Pharmacol. Sin. 26, 1454 (2005).
8. M. Nomi, A. Atala, P.D. Coppi, and S. Soker, Mol. Aspects. Med. 23, 463 (2002).
9. Y.C. Huang, C.T. Chen, and S.C. Chen, Pharmaceutical Res. 22, 636 (2005).
10. D.S. Goodsell, The Oncologist 7, 569 (2002).
11. G.W. De Vries, A. Mc Laughlin, M.B. Wenzel, J. Perez, D. Harcourt, and G. Lee, Inflammation 19, 261 (1995).
12. B.G. Lake and S. Lyubsky, Dig. Dis. Sci. 40, 2349 (1995).
13. G.J. Southan and C. Zabo, Biochem. Pharmacol. 51, 383 (1996).
14. J.S. Pieper, T. Hafmans, P.B. van Wachem, M.J.A. van Luyn, L.A. Brouwer, and J.H. Veerkamp, J. Biomed. Mater. Res. 62, 185 (2002).
15. N. Weidner, J.P. Semple, W.R. Welch, and J. Folkman, N. Engl. J. Med. 324, 1 (1991).
16. D.W. Courtman, B.F. Errett, and G.J. Wilson, J. Biomed. Mater. Res. 55, 576 (2001).